has knowledgeable contact person
Datasets  >  clinical study dataset  >  Phase I long peptide vaccin...

Phase I long peptide vaccination trial in colorectal or ovarium cancer patients

clinical study dataset

We have obtained data from a phase I long peptide vaccination trial with p53 peptides in Montanide adjuvant in patients with colorectal cancer or ovarium cancer. This vaccine was well tolerated and robust p53-specific T cell responses were induced.

In the future we intend to combine the p53 vaccine with other cancer therapies such as chemotherapy.

created over 15 years ago (16 December 2009)    last modified over 12 years ago (14 January 2013)   [ RDF Rdf ]   [ RelFinder Relfinder ]